Navigating Biosimilar Approvals in Southeast Asia: A Strategic Roadmap
As patent cliffs approach for major biologics, Southeast Asian markets present unprecedented opportunities for biosimilar manufacturers. Understanding the regulatory nuances across ASEAN nations is critical for successful market entry.
Dr. Sarah Chen
2026-01-20T09:00:00Z